76 related articles for article (PubMed ID: 7549904)
1. Role of p53 in leukemogenesis of chronic myeloid leukemia.
Lanza F; Bi S
Stem Cells; 1995 Jul; 13(4):445-52. PubMed ID: 7549904
[TBL] [Abstract][Full Text] [Related]
2. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia.
Güran S; Bahçe M; Beyan C; Korkmaz K; Yalçin A
Haematologia (Budap); 1998; 29(3):181-93. PubMed ID: 10069444
[TBL] [Abstract][Full Text] [Related]
3. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
4. Retroviral transduction of Philadelphia-positive chronic myeloid leukemia cells with a human mutant p53 cDNA and its effect on in vitro proliferation.
Bi S; Barton CM; Lemoine NR; Cross NC; Goldman JM
Exp Hematol; 1994 Jan; 22(1):95-9. PubMed ID: 8282066
[TBL] [Abstract][Full Text] [Related]
5. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.
Williams RT; Sherr CJ
Cold Spring Harb Symp Quant Biol; 2008; 73():461-7. PubMed ID: 19028987
[TBL] [Abstract][Full Text] [Related]
6. The involvement of "tumor suppressor" p53 in normal and chronic myelogenous leukemia hemopoiesis.
Bi S; Lanza F; Goldman JM
Cancer Res; 1994 Jan; 54(2):582-6. PubMed ID: 8275497
[TBL] [Abstract][Full Text] [Related]
7. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
8. Model mice for BCR/ABL-positive leukemias.
Honda H; Hirai H
Blood Cells Mol Dis; 2001; 27(1):265-78. PubMed ID: 11358387
[TBL] [Abstract][Full Text] [Related]
9. The abnormal p53 proteins expressed in CML cell lines are non-functional.
Bi S; Lanza F; Goldman JM
Leukemia; 1993 Nov; 7(11):1840-5. PubMed ID: 8231251
[TBL] [Abstract][Full Text] [Related]
10. Deficient cell cycle control in myeloid cells of patients with newly diagnosed chronic myeloid leukemia.
Schwab R; Peschel C; Desprès D; Derigs G; Fischer T; Huber C; Aulitzky WE
Cytokines Mol Ther; 1995 Dec; 1(4):281-8. PubMed ID: 9384681
[TBL] [Abstract][Full Text] [Related]
11. p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
Brusa G; Benvenuti M; Mazzacurati L; Mancini M; Pattacini L; Martinelli G; Barbieri E; Greenberger JS; Baccarani M; Santucci MA
Haematologica; 2003 Jun; 88(6):622-30. PubMed ID: 12801837
[TBL] [Abstract][Full Text] [Related]
12. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
13. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.
Jiang X; Saw KM; Eaves A; Eaves C
J Natl Cancer Inst; 2007 May; 99(9):680-93. PubMed ID: 17470736
[TBL] [Abstract][Full Text] [Related]
14. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
Neubauer A; He M; Schmidt CA; Huhn D; Liu ET
Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
[TBL] [Abstract][Full Text] [Related]
16. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cell kinetics and cell cycle status by treating CD34+ chronic myeloid leukaemia cells with p53 antisense phosphorothioate oligonucleotides.
Lanza F; Bi S; Moretti S; Castoldi G; Goldman JM
Br J Haematol; 1995 May; 90(1):8-14. PubMed ID: 7786800
[TBL] [Abstract][Full Text] [Related]
18. p53 gene alterations in human hematological malignancies: a review.
Soussi T; Jonveaux P
Nouv Rev Fr Hematol (1978); 1991; 33(6):477-80. PubMed ID: 1818301
[TBL] [Abstract][Full Text] [Related]
19. [Mutations of the p53 gene in hematologic neoplasms].
Mori N; Mizoguchi H
Nihon Rinsho; 1992 Jun; 50(6):1353-7. PubMed ID: 1518157
[TBL] [Abstract][Full Text] [Related]
20. A close link between Fas, p53 and Apaf-1 in chronic myeloid leukemia.
Alenzi FQ; Wyse RK; Tamimi WG; Bamaga MS; Lotfy M
Saudi Med J; 2007 Jul; 28(7):1119-21. PubMed ID: 17603723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]